CRISPR-Based Portable Tool Developed for Sensitive Detection of Mpox in Resource-Limited Settings

Researchers have developed a sustainable and portable CRISPR-based diagnostic tool capable of detecting Mpox with high sensitivity. The new method offers a practical approach for identifying the virus, which has posed significant public health challenges in recent years. The diagnostic system combines CRISPR technology with a user-friendly design, making it suitable for use in resource-limited settings.

The study highlights the tool’s ability to detect Mpox at low concentrations, demonstrating its high sensitivity and reliability. Researchers designed the system to be portable and cost-effective, addressing barriers often encountered in traditional diagnostic methods. By leveraging CRISPR’s precision in targeting specific genetic sequences, the device provides accurate results without requiring complex laboratory infrastructure. This advancement could potentially improve early detection and monitoring efforts for Mpox outbreaks worldwide.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

Related posts:

Russian Pharmaceutical Market Reaches $14.5 Billion by 2025, Driven by Generics and Novel Therapies Nagoya University Researchers Develop Blood Test to Detect Polysialic Acid Linked to Schizophrenia Study Links Stronger T Cell Activity to Longer Survival in ALS Patients Researchers Investigate Disrupting Bacterial Communication to Manage Oral Health

Author

GOAI